[
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Epicentre Data Science",
    "section": "",
    "text": "From outbreaks to clinical trials, Epicentre’s data science team (Epi DS) leverages its expertise in epidemiology, statistical analysis, programming and data visualisation to drive actionable insight from public health data.\nBelow is our collection of our interactive dashboards and reports. Use the search bar and categories menu to filter to your areas of interest.\nItems labelled as INTERNAL will require a login. If you are a member of the MSF network and have an msf.org email address you can create an account to access our dashboards on our sign-up page. Note that some dashboards are limited to specific OCs, individual personel or project partners, so not all content will be accessible with your account.\n\n\n\n   \n     \n     \n       Order By\n       Default\n         \n          Title\n        \n         \n          Published - Oldest\n        \n         \n          Published - Newest\n        \n         \n          Updated - Oldest\n        \n         \n          Updated - Newest\n        \n     \n  \n    \n      \n      \n    \n\n\n\n  \n    \n      \n      \n        \n          Niger Surveillance \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  niger\n                \n              \n          \n        \n          Dashboard de la surveillance des maladies au Niger\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          MAGY Study \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  hiv\n                \n              \n              \n                \n                  study\n                \n              \n              \n                \n                  uganda\n                \n              \n              \n                \n                  zambia\n                \n              \n              \n                \n                  south africa\n                \n              \n          \n        \n          Study monitoring and quality control dashboard\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Outbreak Tools GeoApp \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  gis\n                \n              \n              \n                \n                  tool\n                \n              \n          \n        \n          Select administrative boundaries to generate a geobase for an outbreak tools linelist.\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          ENABLE Reporting Dahsboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  study\n                \n              \n              \n                \n                  lassa\n                \n              \n          \n        \n          Project reporting dashboard monitoring enrolment, follow-up and lab data in near real-time\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          GTFCC OCV \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  cholera\n                \n              \n          \n        \n          Dashboard tracking Oral Cholera Vaccine requests and shipments for the Global Task Force on Cholera Control\n      \n      \n      \n        \n          Epi DS\n          active\n          public\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          West Africa Diphtheria \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  diphtheria\n                \n              \n              \n                \n                  nigeria\n                \n              \n              \n                \n                  niger\n                \n              \n          \n        \n          Intersectional diphtheria linelist dashboard\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Nutrition - Nigeria (Katsina) \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  nutrition\n                \n              \n              \n                \n                  nigeria\n                \n              \n          \n        \n          Dashboard visualising OCP malnutrition linelist data\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          ENABLE Interim Analysis \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  study\n                \n              \n              \n                \n                  lassa\n                \n              \n          \n        \n          Report summarising the interim analysis for the Enable Lassa study\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Alerte Niger \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  niger\n                \n              \n          \n        \n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          East Africa Measles \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  measles\n                \n              \n              \n                \n                  sudan\n                \n              \n              \n                \n                  south sudan\n                \n              \n          \n        \n          Intersectional measles linelist dashboard\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          HR Dashboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  hr\n                \n              \n          \n        \n          Monitor Epicentre Staff Activity & Projects\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          ENABLE ELISA Analysis \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  study\n                \n              \n              \n                \n                  lassa\n                \n              \n              \n                \n                  tool\n                \n              \n          \n        \n          Tool to measure IgG concentration in blood serum using an indirect ELISA\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          IAVI X100 LF \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  study\n                \n              \n              \n                \n                  lassa\n                \n              \n          \n        \n          Project reporting dashboard monitoring enrolment, follow-up and lab data in near real-time\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Haïti Surveillance \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  cholera\n                \n              \n          \n        \n          Tableau de bord de la surveillance du choléra et d'autres maladies en Haïti\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          MSF Typology \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  typology\n                \n              \n          \n        \n          Dashboard presenting the typology of the entire MSF movement\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          RDC Choléra \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  cholera\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Tableau de bord de la surveillance du choléra en RDC ; comprenant des visualisations, des tableaux et des rapports centralisés.\n      \n      \n      \n        \n          C. Eisenhauer\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          RDC Rougeole \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  measles\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Tableau de bord de la surveillance de la rougeole en RDC ; comprenant des visualisations, des tableaux et des rapports centralisés.\n      \n      \n      \n        \n          C. Eisenhauer\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          OCV Impact \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  cholera\n                \n              \n          \n        \n          Dashboard de surveillance clinique pour l'étude OCV Impact Wellcome\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          COVID-19 Epi Dashboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  covid19\n                \n              \n          \n        \n          Dashboard to monitor the global spread of the COVID-19 pandemic\n      \n      \n      \n        \n          Epi DS\n          active\n          public\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          ENABLE Quality Control \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  study\n                \n              \n              \n                \n                  lassa\n                \n              \n          \n        \n          Quality control dashboard for query management and follow-up scheduling\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Ebola Uganda 2022 \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  uganda\n                \n              \n          \n        \n          Dashboard tracking the 2022 ebola outbreak in Uganda\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          MSF COVID-19 Additional Analysis \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  covid19\n                \n              \n          \n        \n          Supplementary graphics and tables\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Ebola DRC 13ème épidémie \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Dashboard displaying ETC linelist compilation data\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          MSF COVID-19 Dashboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  covid19\n                \n              \n          \n        \n          Visualisation of COVID-19 linelist data collected on MSF missions\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Ebola DRC 12ème épidémie \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Dashboard displaying ETC linelist compilation data.\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Ebola Equateur DRC \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Dashboard to visualise linelist data of the ebola outbreak in Equatuer, DRC\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          COVID-19 Modelling Tool \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  tool\n                \n              \n              \n                \n                  modelling\n                \n              \n              \n                \n                  covid19\n                \n              \n          \n        \n          Estimate the demand for hospitalization and operational resources for COVID patients in locations of your choice\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Alertes COVID-19 Niger \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  niger\n                \n              \n              \n                \n                  covid19\n                \n              \n          \n        \n          Dashboard to visualise COVID-19 alert reports received by the Medic Mobile application.\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          DRC-EB-001 (Tujiokowe) Daily Situation Report (EN) \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  trial\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Daily data from the J&J vaccine trial in Kivu, DRC\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          DRC-EB-001 (Tujiokowe) Rapport de Situation Quotidien (FR) \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  trial\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Daily data from the J&J vaccine trial in Kivu, DRC\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          DRC-EB-001 (Tujiokowe) Query Dashboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  trial\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Monitor status of data queries\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          DRC-EB-001 (Tujiokowe) Follow-up Dashboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  trial\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Monitor status of subset follow-ups\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          J&J Zebovac Uganda Dashboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  study\n                \n              \n              \n                \n                  trial\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  uganda\n                \n              \n          \n        \n          Monitor progress of the immunogenicity and safety trial of the J&J Vebovaccine in Mbarara, Uganda.\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n\n\nNo matching items"
  },
  {
    "objectID": "index.html#data-visualisation-gallery",
    "href": "index.html#data-visualisation-gallery",
    "title": "Epicentre Data Science",
    "section": "",
    "text": "From outbreaks to clinical trials, Epicentre’s data science team (Epi DS) leverages its expertise in epidemiology, statistical analysis, programming and data visualisation to drive actionable insight from public health data.\nBelow is our collection of our interactive dashboards and reports. Use the search bar and categories menu to filter to your areas of interest.\nItems labelled as INTERNAL will require a login. If you are a member of the MSF network and have an msf.org email address you can create an account to access our dashboards on our sign-up page. Note that some dashboards are limited to specific OCs, individual personel or project partners, so not all content will be accessible with your account.\n\n\n\n   \n     \n     \n       Order By\n       Default\n         \n          Title\n        \n         \n          Published - Oldest\n        \n         \n          Published - Newest\n        \n         \n          Updated - Oldest\n        \n         \n          Updated - Newest\n        \n     \n  \n    \n      \n      \n    \n\n\n\n  \n    \n      \n      \n        \n          Niger Surveillance \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  niger\n                \n              \n          \n        \n          Dashboard de la surveillance des maladies au Niger\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          MAGY Study \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  hiv\n                \n              \n              \n                \n                  study\n                \n              \n              \n                \n                  uganda\n                \n              \n              \n                \n                  zambia\n                \n              \n              \n                \n                  south africa\n                \n              \n          \n        \n          Study monitoring and quality control dashboard\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Outbreak Tools GeoApp \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  gis\n                \n              \n              \n                \n                  tool\n                \n              \n          \n        \n          Select administrative boundaries to generate a geobase for an outbreak tools linelist.\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          ENABLE Reporting Dahsboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  study\n                \n              \n              \n                \n                  lassa\n                \n              \n          \n        \n          Project reporting dashboard monitoring enrolment, follow-up and lab data in near real-time\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          GTFCC OCV \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  cholera\n                \n              \n          \n        \n          Dashboard tracking Oral Cholera Vaccine requests and shipments for the Global Task Force on Cholera Control\n      \n      \n      \n        \n          Epi DS\n          active\n          public\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          West Africa Diphtheria \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  diphtheria\n                \n              \n              \n                \n                  nigeria\n                \n              \n              \n                \n                  niger\n                \n              \n          \n        \n          Intersectional diphtheria linelist dashboard\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Nutrition - Nigeria (Katsina) \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  nutrition\n                \n              \n              \n                \n                  nigeria\n                \n              \n          \n        \n          Dashboard visualising OCP malnutrition linelist data\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          ENABLE Interim Analysis \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  study\n                \n              \n              \n                \n                  lassa\n                \n              \n          \n        \n          Report summarising the interim analysis for the Enable Lassa study\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Alerte Niger \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  niger\n                \n              \n          \n        \n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          East Africa Measles \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  measles\n                \n              \n              \n                \n                  sudan\n                \n              \n              \n                \n                  south sudan\n                \n              \n          \n        \n          Intersectional measles linelist dashboard\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          HR Dashboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  hr\n                \n              \n          \n        \n          Monitor Epicentre Staff Activity & Projects\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          ENABLE ELISA Analysis \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  study\n                \n              \n              \n                \n                  lassa\n                \n              \n              \n                \n                  tool\n                \n              \n          \n        \n          Tool to measure IgG concentration in blood serum using an indirect ELISA\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          IAVI X100 LF \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  study\n                \n              \n              \n                \n                  lassa\n                \n              \n          \n        \n          Project reporting dashboard monitoring enrolment, follow-up and lab data in near real-time\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Haïti Surveillance \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  cholera\n                \n              \n          \n        \n          Tableau de bord de la surveillance du choléra et d'autres maladies en Haïti\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          MSF Typology \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  typology\n                \n              \n          \n        \n          Dashboard presenting the typology of the entire MSF movement\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          RDC Choléra \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  cholera\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Tableau de bord de la surveillance du choléra en RDC ; comprenant des visualisations, des tableaux et des rapports centralisés.\n      \n      \n      \n        \n          C. Eisenhauer\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          RDC Rougeole \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  measles\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Tableau de bord de la surveillance de la rougeole en RDC ; comprenant des visualisations, des tableaux et des rapports centralisés.\n      \n      \n      \n        \n          C. Eisenhauer\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          OCV Impact \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  cholera\n                \n              \n          \n        \n          Dashboard de surveillance clinique pour l'étude OCV Impact Wellcome\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          COVID-19 Epi Dashboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  covid19\n                \n              \n          \n        \n          Dashboard to monitor the global spread of the COVID-19 pandemic\n      \n      \n      \n        \n          Epi DS\n          active\n          public\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          ENABLE Quality Control \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  study\n                \n              \n              \n                \n                  lassa\n                \n              \n          \n        \n          Quality control dashboard for query management and follow-up scheduling\n      \n      \n      \n        \n          Epi DS\n          active\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Ebola Uganda 2022 \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  uganda\n                \n              \n          \n        \n          Dashboard tracking the 2022 ebola outbreak in Uganda\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          MSF COVID-19 Additional Analysis \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  covid19\n                \n              \n          \n        \n          Supplementary graphics and tables\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Ebola DRC 13ème épidémie \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Dashboard displaying ETC linelist compilation data\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          MSF COVID-19 Dashboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  covid19\n                \n              \n          \n        \n          Visualisation of COVID-19 linelist data collected on MSF missions\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Ebola DRC 12ème épidémie \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Dashboard displaying ETC linelist compilation data.\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Ebola Equateur DRC \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Dashboard to visualise linelist data of the ebola outbreak in Equatuer, DRC\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          COVID-19 Modelling Tool \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  tool\n                \n              \n              \n                \n                  modelling\n                \n              \n              \n                \n                  covid19\n                \n              \n          \n        \n          Estimate the demand for hospitalization and operational resources for COVID patients in locations of your choice\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          Alertes COVID-19 Niger \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  surveillance\n                \n              \n              \n                \n                  niger\n                \n              \n              \n                \n                  covid19\n                \n              \n          \n        \n          Dashboard to visualise COVID-19 alert reports received by the Medic Mobile application.\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          DRC-EB-001 (Tujiokowe) Daily Situation Report (EN) \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  trial\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Daily data from the J&J vaccine trial in Kivu, DRC\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          DRC-EB-001 (Tujiokowe) Rapport de Situation Quotidien (FR) \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  trial\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Daily data from the J&J vaccine trial in Kivu, DRC\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          DRC-EB-001 (Tujiokowe) Query Dashboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  trial\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Monitor status of data queries\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          DRC-EB-001 (Tujiokowe) Follow-up Dashboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  trial\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  drc\n                \n              \n          \n        \n          Monitor status of subset follow-ups\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n  \n    \n      \n      \n        \n          J&J Zebovac Uganda Dashboard \n         \n      \n      \n      \n        \n            \n        \n      \n      \n      \n        \n          \n              \n                \n                  study\n                \n              \n              \n                \n                  trial\n                \n              \n              \n                \n                  ebola\n                \n              \n              \n                \n                  uganda\n                \n              \n          \n        \n          Monitor progress of the immunogenicity and safety trial of the J&J Vebovaccine in Mbarara, Uganda.\n      \n      \n      \n        \n          Epi DS\n          archived\n          internal\n        \n      \n    \n  \n\n\nNo matching items"
  }
]